Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Cited by (687)

Items 601–687 of 687

1. Stratégies thérapeutiques pour l’application clinique des ARN interférents
   Elias Fattal · 2020 · Bulletin de l Académie Nationale de Médecine
2. Construction of synthetic life forms with genetic materials comprising unnatural nucleic acids
   Yanfen Bai, Peng Nie, Chenghe Xiong, Junlin Wen, Haiyun Gan, Qing Ma, Zheng Hu, Xuefei Li, Tao Yu, Jiandong Huang et al. · 2020 · Chinese Science Bulletin (Chinese Version)
3. Therapeutic strategies for modulating epigenetic mechanisms in cardiovascular disease
   Johannes Winkler · 2021 · Elsevier eBooks
4. Tools and Technologies for Cartilage Repair
   João P. Garcia · 2021
5. Intra and extracellular responses to DNA damage
   Mark Fisher · 2021 · Queensland University of Technology
6. Oligonucleotide Therapy
   Michela A. Denti, Giuseppina Covello · 2017 · Springer eBooks
7. DNA Repair Pathways in the Context of Therapeutic Genome Editing
   Sandra Wimberger, Nina Akrap, Amir Taheri‐Ghahfarokhi · 2022 · Wiley eBooks
8. P–S Bonds: Phosphorothioates
   2020 · Royal Society of Chemistry eBooks
9. Faculty Opinions recommendation of Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.
   Sue Fletcher · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
10. Modification-Dependent Restriction Endonuclease-based sequencing method (EcoWI-seq) maps the genome-wide landscape of phosphorothioate modification at base resolution
    Weiwei Yang, Alexey I. Fomenkov, Dan Heiter, Shuang-yong Xu, Laurence M. Ettwiller · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
11. Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in vivo in CNS
    Faith Conroy, Rachael Miller, Julia F. Alterman, Matthew R. Hassler, Dimas Echeverria, Bruno M.D.C. Godinho, Emily G. Knox, Ellen Sapp, Jaquelyn Sousa, Ken Yamada et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
12. Macrophage-targeted oligonucleotide therapeutics to downregulate inflammatory cytokines in non-alcoholic steatohepatitis
    Kevin Craig · 2021
13. New Molecular Technologies for Oligonucleotide Therapeutics-1: Properties and Synthesis of Boranophosphate DNAs
    Kazuki Sato, Takeshi Wada · 2022 · Springer eBooks
14. Synthesis of Dinucleotide Non‐Symmetrical Triester Phosphate Phosphoramidites and Their Incorporation Within Oligonucleotides
    Jean‐Paul Desaulniers, Kouta Tsubaki, Matthew L. Hammill, Mitsuru Kitamura, Tatsuo Okauchi · 2023 · Current Protocols
15. Selecting Therapeutic Antisense Oligonucleotides with Gene Targeting and TLR8 Potentiating Bifunctionality
    Sunil Sapkota, Michael Paul Gantier · 2023 · Methods in molecular biology
16. New Molecular Technologies for Oligonucleotide Therapeutics-1: Properties and Synthesis of Boranophosphate DNAs
    Kazuki Sato, Takeshi Wada · 2023 · Springer eBooks
17. Application of the weighted histogram method for calculating the thermodynamic parameters of the formation of oligodeoxyribonucleotide duplexes
    Ivan I. Yushin, Victor M. Golyshev, Dmitrii V. Pyshnyi, Alexander A. Lomzov · 2023 · Vavilov Journal of Genetics and Breeding
18. Antisense Oligonucleotides in Eukaryotes
    Anke Kurreck, Jens Kurreck · 2024 · Elsevier eBooks
19. Synthesis and Properties of RNA Modified with Thioamide Internucleoside Linkage
    Sayed Habibul Gafur, Samir Ghosh, Michael Richter, Eriks Rozners · 2024 · ChemBioChem
20. Nucleic acids as drug targets
    Bùi Thanh Tùng, Vu Thi Thu Trang, Nguyễn Thị Vân Anh · 2024 · Elsevier eBooks
21. Harnessing sulfur-binding domains to separate Sp and Rp isomers of phosphorothioate oligonucleotides
    Fulin Ge, Yuli Wang, Jinling Liu, Hao Yu, Guang Liu, Zixin Deng, Xinyi He · 2024 · Applied Microbiology and Biotechnology
22. SCAD Delivery Platform: A Novel Approach for Efficient CNS and Extrahepatic Oligonucleotide Therapeutics
    Moorim Kang, Wei-Hsiang Lin, Feifei Xu, Xiaojie Zhou, Chunyan Si, Kunshan Liu, Jian Dai, J. He, Ian Schacht, Yichen Li et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
23. Nucleic Acids Production
    Natalia Sol Adler, Ana Sol Peinetti · 2024 · Topics in medicinal chemistry
24. Synthesis and structural analysis of dinucleotides containing 2′,3′-trans-bridged nucleic acids with trans-5,6- or 5,7-fused ring skeleton
    Takashi Osawa, Ryota Nakanishi, Keito Uda, So Muramoto, Satoshi Obika · 2025 · Communications Chemistry
25. SCAD: A Modular Platform for Efficient Delivery of Duplex RNA to the CNS and Beyond
    Long‐Cheng Li, Moorim Kang, Wei-Hsiang Li, Feifei Xu, Xiaojie Zhou, Chunyan Si, Jian Dai, J. He, Ian Schacht, Yichen Li et al. · 2025 · Research Square
26. Antithrombotic Effect of a Bivalent DNA Aptamer of Thrombin
    Yanxi Chen, Shoubo Xiang, Chunfa Chen, Qiuyu Su, Zhe Zhang, Yangyang Fan, Zhihong Cui, Lixue Yin, Hua Zuo, Mingliang Zuo · 2025 · ACS Biomaterials Science & Engineering
27. Manufacturing of oligonucleotides
    Eduardo Paredes, Vincent Aduda, Kathryn L. Ackley, Hagen Cramer · 2025 · Elsevier eBooks
28. RNA Nanotechnology: The Fundamentals
    Phei Er Saw, Erwei Song · 2025 · Springer eBooks
29. A Convenient Fluorogenic Detection Strategy for Phosphorothioate Modification of DNA Through Photocatalytic Oligonucleotide-Templated Reaction
    Nannan Jing, Yantian Qin, Xinli Fan, Qian Wang, Jing Wang, Fuping You, Xinjing Tang · 2025 · Biomolecules
30. A rapid and robust protocol for generating loss-of-function alleles in pluripotent stem cells
    Erdene Baljinnyam, Laura Grisanti, Tattari Shalini, Chiara Pedicone, Bhavana Shewale, Nicole Dubois, Alison Goate, William Garrow Kerr, Samuele G. Marro · 2025 · STAR Protocols
31. Modified Nucleic Acids
    Wentao Xu · 2025 · Springer eBooks
32. Developing Methods for the Synthesis of Ligand–Oligonucleotide Conjugates for Drug Discovery Applications
    Takashi Osawa · 2025 · Chemical and Pharmaceutical Bulletin
33. Molecular treatment options for patients carrying KIAA0586/TALPID3 variants
    Jacqueline E Taudien, Sebastian Swirski, Maike Möller, Christoph Jüschke, Marta Owczarek‐Lipska, Georg Christoph Korenke, John Neidhardt · 2025 · Molecular Therapy — Nucleic Acids
34. Synthesis, Biological Activity, and Molecular Dynamics Simulations of LNA‐Charge Neutral Linkages for Enhanced Splice‐Switching Antisense Oligonucleotides
    Alice M. R. Kennett, Lillian Lie, Martin Flerin, Belma Zengin Kurt, Ysobel R. Baker, Alyssa C. Hill, Abinaya Ramesh, Matthew J. A. Wood, Debashis Dhara, Afaf Helmy El-Sagheer et al. · 2025 · Angewandte Chemie
35. Simple in vitro single-stranded linear and circular DNA preparation, functional selection, and validation using phosphor-derived modifications
    Seyed Vahid Hamidi, Vanessa Aguilar-Sánchez, Vincent Héroux, Jonathan Perreault · 2025 · Journal of Biological Chemistry
36. Developing antisense therapeutics for multiple myeloma
    Alexander Kapphahn, Nikki Truong, Mahnoor Khan, Annaliza Ashitey, Dominic Alfano, Anisha Gupta · 2025 · Cell Reports Physical Science
37. Unveiling Liver Micro-Distribution: NanoSIMS Imaging Reveals Critical Intracellular Distribution of Chemically Modified Antisense Oligonucleotides
    Hidenori Yasuhara, Kenta Kadotsuji, Kenichi Watanabe, Tomomi Kakutani, Tomoaki Tochitani, Izuru Mise, Mei Konishi, Tetsuya Nakagawa, Izuru Miyawaki · 2025 · Nucleic Acid Therapeutics
38. Additional file 1 of Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair
    Li, Guoling, Xiaohui Yang, Luo, Xinxin, Wu, Zhenfang, Yang, Huaqiang · 2024 · Figshare
39. Additional file 3 of Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair
    Li, Guoling, Xiaohui Yang, Luo, Xinxin, Wu, Zhenfang, Yang, Huaqiang · 2024 · Figshare
40. Additional file 2 of Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair
    Li, Guoling, Xiaohui Yang, Luo, Xinxin, Wu, Zhenfang, Huaqiang Yang · 2024 · Figshare
41. Nucleic acid–inspired phosphorus-containing polymers
    Yuchen Ma, Yuwei Gu · 2025 · European Polymer Journal
42. Developing artificial cytoskeletons using RNA origami-based nanotubes
    Md. Tanvir Ahmed, Kazi Tasnuva Alam · 2026 · Progress in Biophysics and Molecular Biology
43. Introduction to RNAi therapeutics
    Naveen Bunekar · 2026 · Elsevier eBooks
44. Surface Plasmon Resonance Analysis for Evaluating ASO Targeting Structured RNA
    Tomohiro Shinozaki, Takuya Hasegawa, MST Tahmina Akter, Kazuyuki Kumagai, Youichi Suzuki, Taiichi Sakamoto · 2026 · Methods and Protocols
45. Description d'une approche thérapeutique de précision dans le mélanome métastatique : utilisation d'oligonucléotides antisens
    Emmanuelle Donnou‐Fournet · 2016 · theses.fr (ABES)
46. étude structurale et fonctionnelle de la protéine a1 du bactériophage t5 : une dnase octamérique originale
    Léo Zangelmi · 2018
47. Comprendre les mécanismes d’action d’Hsp27 conduisant à la résistance à la castration des cancers de la prostate
    Chaïma Cherif · 2019
48. Chalcogen-modified Nucleic Acid Analogues
    Katarzyna Kulik, Barbara Nawrot · 2026 · Current Medicinal Chemistry
49. Le développement préclinique des tcDNA pour la Dystrophie Musculaire de Duchenne
    Philippine Aupy · 2019 · theses.fr (ABES)
50. Nouvelle stratégie de synthèse vers des analogues homo-et hétérodinucléotiques stables incorporant un motif difluorophosphin(othio)ate
    Rita El Hindi · 2023 · theses.fr (ABES)
51. Développement d’une nouvelle approche thérapeutique basée sur l’interférence à ARN (siRNA) pour traiter les maladies neurodégénératives et les leucodystrophies du système nerveux central
    Guy Khalaf · 2023 · theses.fr (ABES)
52. Amidation of Phosphonoacetate-Modified Oligonucleotides and Evaluation of the Properties of the Synthesized Oligonucleotides
    Takashi Osawa, Ryusei Yamashita, Haruki Koyama, Daiki Fujisue, Satoshi Obika · 2026 · Organic Letters
53. Dynamics of an RNase H-Responsive Tetrahedral DNA Nanostructure for Efficient Intracellular microRNA Inhibition
    Ana S. G. Martins, Sara Reis, Ruxandra Baboi, Francisco Furlan, João Cortinhas, Filomena A. Carvalho, Nuno C. Santos, Jonathan Bath, Erik Benson, Ana Paula Pêgo et al. · 2026 · Bioconjugate Chemistry
54. Backbone extension by methylene insertion as a strategy to restore duplex stability of sulfonamide-linked oligodeoxynucleotides while preserving RNase H activity
    Kohji Seio, Hiroki Mikagi, Haruka Tanabe, Shigetoshi Tachibana, Y. MASAKI, Eitaro Murakami · 2026 · Organic & Biomolecular Chemistry
55. Expanding the chemical diversity of RNA by transcriptional incorporation of amino acid- and glycosyl-modified nucleotides
    Julián Valero, Kevin Neis, Laia Civit, Søren Fjelstrup, Maria Gockert, Jørgen Kjems · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
56. Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides
    Halle M. Barber, Mansi Parasrampuria, Jerónimo Jurado‐Arjona, Andrea Gamir-Morralla, Benedikt Berninger, Carlos González, Keith T. Gagnon, Masad José Damha, Miguel Garavís · 2026 · Nucleic Acids Research
57. A highly sensitive detection platform for scrub typhus using multi-fluorescence nucleic acid probes and STORM imaging
    Tianyu Chen, Shu Yang, Yu Feng Zhang, Xiaoling Zhang, Ting Xiong, Mengzhu Guo, Hui Li, Xian Feng Hao · 2026 · Analytica Chimica Acta
58. Design and Applications of Riboregulators
    Dimitrios Kaloudas, Martina Traykovska, Nikolet Pavlova, Prof. Robert Penchovsky, Dr. rer. nat. · 2026 · Springer eBooks
59. Non-coding RNAs: Therapeutic Implications in Cancers
    Raquel Alves, Joana Jorge, Maria Inês Costa, Beatriz Lapa, Ana Bela Sarmento‐Ribeiro, Ana Cristina Gonçalves · 2026 · Cancer drug discovery and develogment/Cancer drug discovery and development
60. Physicochemical convergence in antibody CDR3-VH repertoires recognizing phosphorothioate-modified oligonucleotides backbone
    Riccardo Galasso, Francesco Coppolino, Alessia Berbiglia, Grete Francesca Privitera, Agata Famà, Giuseppe Valerio De Gaetano, Germana Lentini, Concetta Beninati · 2026 · Frontiers in Immunology
61. Thio-modification effects on mRNA translation using a PureCap-based capping method
    Zheyu Meng, Yiwei Liu, Yuko Nakashima, Masahito Inagaki, Seigo Kimura, Yukari Kondo, Fumitaka Hashiya, Naoko Abe, Noriko Saito–Tarashima, Noriaki Minakawa et al. · 2026 · RSC Chemical Biology
62. 5′-Palmitate Lipid and Internal LNA-Piperidyl Triesters Enhance the RNA Affinity and Activity of Splice-Switching Oligonucleotides
    Debashis Dhara, Tom P Brown · 2026 · Journal of the American Chemical Society
63. MicroRNA-Based Therapeutic Strategies for Pulmonary Arterial Hypertension under Different Delivery Systems: Progress and Challenges
    Jiaxiang Chen, Xiaoyu Zhang, J N Zhang, Haobo Ren, Jiahui Xie, Runwei Ma · 2026 · Current Medicinal Chemistry
64. Acyclic artificial nucleic acid substitution expands the safe design space of gapmer ASOs by preventing P54nrb mislocalization
    Jumpei Ariyoshi, Masaya Higuchi, Hiroyuki Oyama, Hiroyuki Asanuma, Yukiko Kamiya · 2026 · NAR Molecular Medicine
65. The Hallmarks of Glioblastoma: Functional Interplay Between Long Non-Coding RNAs and RNA-Binding Proteins
    Karlijn A. van de Langerijt, Md. Golam Kibria, Genaro R. Villa, Marco Mineo · 2026 · Cells
66. The splice of life: an isoform-centric view of disease, technology, and therapeutics
    Timothy Pan, Lina Lu, Ruli Gao · 2026 · Journal of Clinical Investigation
67. Consideration for immunogenicity assay development for oligonucleotide therapeutics
    Amily Fang‐Ju Jou, Kelly M. Hainline · 2026 · Bioanalysis
68. Therapeutic potential of antisense oligonucleotides in hematological malignancies
    Élie Cousin, Agathe Picard, Elfie Perrudin, Maria Oundjian, Nina Tardif, Anaïs M. Quéméner, Anne-Gaëlle Rio, Marie‐Dominique Galibert, Virginie Gandemer, Frédéric Mazurier · 2026 · Biomedicine & Pharmacotherapy
69. An investigation into uptake and delivery of oligonucleotides in Candida
    Antwine W. McFarland, Sandra P. Story, Dev P. Arya · 2026 · Bioorganic & Medicinal Chemistry
70. Chiral phosphorus by catalyst design
    Kyle W. Knouse, David Butler · 2026 · Nature Catalysis
71. Efficient Oxidative Cross‐Coupling of Sulfonylhydrazides With Phosphites for the Synthesis of Phosphorothioates
    Savita Gat, Rana Chatterjee, Rambabu Dandela · 2026 · ChemistrySelect
72. Advances in antisense technology for cardiovascular drug discovery: from gene silencing to therapeutics
    Deung-Dae Park, Anja Bühler, Christian Schöllhorn, Steffen Just · 2026 · Expert Opinion on Drug Discovery
73. Detection of Unlabeled Oligonucleotides in FFPE Tissue Sections Using Automated miRNAscope Assays
    Bradley Spencer‐Dene · 2026 · Methods in molecular biology
74. Optimized Multi-Phosphorothioate Linkers Enable Efficient Iodine-Induced Cleavage of Surface-Immobilized DNA for Genomic Applications
    Qiqi Cai, Zijie Xiao, Qingbin Chen, 徐杰诚, Huihua Xia, Luyang Zhao, Erkai Liu, Shuguang Xuan · 2026 · ACS Omega
75. Phosphate backbone epitranscriptomics: Discovery of natural RNA phosphorothioates and their writer machinery
    Alexander Maman, Yuko Nobe, Kristin A. Fluke, Katrin Weidenbach, Alexandra N. Harte, Brett W. Burkhart, Jakub Nowak, Priyadarshini Mukherjee, Deepak Kumar Choudhary, Anatoly Kustanovich et al. · 2026 · Cell
76. Engineering of a plant ribosylated nucleotide immune second messenger
    Steven Cheng, Julian Strippel, Federica Locci, Alexander Mandel, Maria Chalikiopoulou, Christof Domnick, Katharina M. Klupsch, Tak H. Lee, Mai Trinh Nguyen, Silvina Perin et al. · 2026 · Research Square
77. Therapeutic oligonucleotides as genetic medicines: The current state and future perspective
    Bruno M.D.C. Godinho, Chantal M. Ferguson, Annemieke M Aartsma-Rus · 2026 · Cell Reports Medicine
78. RNA therapeutics: current status and future directions
    Barbara Yang, Melina J. Sedano, Karla L. Perez, Mahalakshmi Vijayaraghavan, Victoria A. Reid, Murali Mohan Yallapu, Subhash C. Chauhan, Subramanian Dhandayuthapani, Enrique Ramos, Shrikanth S. Gadad · 2026 · Signal Transduction and Targeted Therapy
79. A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown
    Joanna E. Parkes, Caecilie M. M. Benckendorff, A. Malinowska, Jacob Roberts, Harley L. Huynh, Sritama Bose, Loïc M. Cochard, Aisling Ní Cheallaigh, Sarah L. Lovelock, Peter L. Oliver et al. · 2026 · ChemBioChem
80. Antisense Oligonucleotide-Mediated Degradation of Toxic RNA in Myotonic Dystrophy Type 1
    Quynh Nguyen, Faiyza Akil Shaikh, Hidenori Moriyama, Toshifumi Yokota · 2026 · Methods in molecular biology
81. Tissue Pharmacokinetics of Antisense Oligonucleotides
    Fang-Ching Chao, Sebastian Sten, Erica Bäckström, Pär Matsson, Peter Gennemark · 2026 · Methods in molecular biology
82. LncRNA Knockdown Using Gapmer Antisense Oligonucleotides
    Kim A. Lennox, Mark A. Behlke · 2026 · Methods in molecular biology
83. Delivery architectures for oligonucleotide therapeutics in genetic and rare diseases: GalNAc-based hepatocyte targeting and extrahepatic translation
    Chan Hyeok Lee, Hyunjun Moon, Kang Hyeok Lee, Jin Hee Na, Jeong Uk Choi, Jin Woo Choi, Sangmin Lee · 2026 · Journal of Controlled Release
84. Synthesis of Chiral α-Aminophosphonate Derivatives through Copper(I)-Catalyzed Enantioselective Alkylation
    Ziqing Wang, Hu Tian, Hongming Zhang, Jun-Zhao Xiao, Liang Yin · 2026 · ACS Catalysis
85. Separation of phosphodiester impurities from fully phosphorothioate-modified oligonucleotides by ion-pair reversed-phase liquid chromatography
    Ryutaro Takamine, Takao Yamaguchi, Takao Inoué, Junji Kawakami, Satoshi Obika · 2026 · Journal of Chromatography A
86. Targeting the cGAS–STING Pathway in Cancer Therapy: A Quantum Biology Perspective on Aging and Anti-Aging Strategies
    Majid Monajjemi, Fatemeh Mollaamin, Şirin Zeynep Haskılıç, Seda Nur Madak, Alper Yaman, Fatma Nur Kabakoz, Fatma Ceren Çetinkaya, Büşra Özcan, Beyza Esenyel, Kubra Say et al. · 2026 · Biointerface Research in Applied Chemistry
87. Recent Advances in Reversed‐Phase Liquid Chromatography for Therapeutic Oligonucleotide and Conjugate Characterization: From Ion‐Pairing to Green Analytical Approaches
    Quang-Dong Bui, Weronika Hewelt-Belka, Tiny Deschrijver, Martin Gilár, Sebastiaan Eeltink · 2026 · Analytical Science Advances